Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumor · Metastatic Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Cancer Centre, Singapore, Singapore, Singapore
Contact: Study coordinator (Amit Jain, MBBS, MRCP (UK), MMed) · amit.jain@singhealth.com.sg · 64368620

Study leads

Dr Amit Jain, MBBS, MRCP (UK), MMed
Principal Investigator
National Cancer Centre, Singapore

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Locally Advanced Solid Tumor · Metastatic Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Irvine, United States · Sacramento, United States

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Solid Tumor

Abroad (travel likely)RecruitingEARLY_PHASE1

Tianjin, China

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Jinan, China

KN035 for dMMR/MSI-H Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE2

Beijing, China